Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124769123 | 12476912 | 3 | F | 201603 | 20160919 | 20160617 | 20160926 | EXP | US-ALEXION-A201604454 | ALEXION | 69.33 | YR | M | Y | 99.20000 | KG | 20160926 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124769123 | 12476912 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 1200 MG, QW | T2-AE1229B01 | 125166 | 1200 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | |||||
| 124769123 | 12476912 | 2 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Unknown | 50 MG, UNK | 0 | 50 | MG | INJECTION | |||||||
| 124769123 | 12476912 | 3 | C | SOLU-CORTEF | HYDROCORTISONE SODIUM SUCCINATE | 1 | Unknown | 100 MG, UNK | 0 | 100 | MG | INJECTION | |||||||
| 124769123 | 12476912 | 4 | C | HEPARIN FLUSH | HEPARIN SODIUM | 1 | Unknown | 500 IU, 100 UNIT/ML | 0 | 500 | IU | INJECTION | |||||||
| 124769123 | 12476912 | 5 | C | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Unknown | 125 MG, UNK | 0 | 125 | MG | INJECTION | |||||||
| 124769123 | 12476912 | 6 | C | PEPCID | FAMOTIDINE | 1 | Unknown | 20 MG, UNK | 0 | 20 | MG | INJECTION | |||||||
| 124769123 | 12476912 | 7 | C | EPINEPHRINE. | EPINEPHRINE | 1 | Unknown | 0.3 MG, UNK | 0 | .3 | MG | INJECTION | |||||||
| 124769123 | 12476912 | 8 | C | OXYGEN. | OXYGEN | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124769123 | 12476912 | 1 | Haemolytic uraemic syndrome |
| 124769123 | 12476912 | 2 | Product used for unknown indication |
| 124769123 | 12476912 | 3 | Product used for unknown indication |
| 124769123 | 12476912 | 4 | Product used for unknown indication |
| 124769123 | 12476912 | 5 | Product used for unknown indication |
| 124769123 | 12476912 | 6 | Product used for unknown indication |
| 124769123 | 12476912 | 7 | Product used for unknown indication |
| 124769123 | 12476912 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124769123 | 12476912 | OT |
| 124769123 | 12476912 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124769123 | 12476912 | Asthenia | |
| 124769123 | 12476912 | Clostridium difficile infection | |
| 124769123 | 12476912 | Dehydration | |
| 124769123 | 12476912 | Full blood count abnormal | |
| 124769123 | 12476912 | Haemolytic uraemic syndrome | |
| 124769123 | 12476912 | Inappropriate schedule of drug administration | |
| 124769123 | 12476912 | Laboratory test abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |